# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001776985-24-000027
Filing Date
2024-03-20
Accepted
2024-03-20 07:57:34
Documents
152
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | bntx-20231231.htm iXBRL | 20-F | 5104761
2 | EX-2.4 | exhibit24descriptionofsecu.htm | EX-2.4 | 180687
3 | EX-4.47 | exhibit447instadeepamendme.htm | EX-4.47 | 1318599
4 | EX-4.48 | exhibit448oncoc4agreementr.htm | EX-4.48 | 731665
5 | EX-4.49 | exhibit449oncoc4amendmentr.htm | EX-4.49 | 23194
6 | EX-4.50 | exhibit450dualityher2agree.htm | EX-4.50 | 472190
7 | EX-4.51 | exhibit451dualityb7h3agree.htm | EX-4.51 | 583932
8 | EX-4.52 | exhibit452dualitytrop2agre.htm | EX-4.52 | 569892
9 | EX-4.53 | exhibit453biotheusagreemen.htm | EX-4.53 | 687749
10 | EX-4.54 | exhibit454autoluslicensean.htm | EX-4.54 | 735163
11 | EX-8 | exhibit8subsidiariesfy2023.htm | EX-8 | 23717
12 | EX-12.1 | exhibit121certification-us.htm | EX-12.1 | 12309
13 | EX-12.2 | exhibit122certification-jh.htm | EX-12.2 | 12298
14 | EX-13.1 | exhibit131certification-us.htm | EX-13.1 | 6977
15 | EX-13.2 | exhibit132certification-jh.htm | EX-13.2 | 6966
16 | EX-15.1 | exhibit151eyconsent20-f.htm | EX-15.1 | 3875
17 | EX-97 | exhibit97biontechcompensat.htm | EX-97 | 24794
23 |  | bntx-20231231_g1.jpg | GRAPHIC | 172708
24 |  | bntx-20231231_g2.jpg | GRAPHIC | 104350
25 |  | bntx-20231231_g3.jpg | GRAPHIC | 126198
26 |  | bntx-20231231_g4.jpg | GRAPHIC | 56437
27 |  | image_0.jpg | GRAPHIC | 12125
28 |  | image_01.jpg | GRAPHIC | 33230
| Complete submission text file | 0001776985-24-000027.txt |  | 26124022

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
18 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bntx-20231231.xsd | EX-101.SCH | 151619
19 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bntx-20231231_cal.xml | EX-101.CAL | 126998
20 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bntx-20231231_def.xml | EX-101.DEF | 613838
21 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bntx-20231231_lab.xml | EX-101.LAB | 1133563
22 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bntx-20231231_pre.xml | EX-101.PRE | 861050
155 | EXTRACTED XBRL INSTANCE DOCUMENT | bntx-20231231_htm.xml | XML | 3307184

Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190840
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39081 | Film No.: 24766314
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)